Open AccessLixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance
Author(s) -
Martin Whyte,
Fariba ShojaeeMoradie,
Sharaf E. Sharaf,
Nicola Jackson,
Barbara A. Fielding,
Roman Hovorka,
Jeewaka Mendis,
David RussellJones,
A. Margot Umpleby
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01176
Subject(s) - lixisenatide , postprandial , medicine , chylomicron , endocrinology , type 2 diabetes , gastric emptying , chemistry , triglyceride , insulin , very low density lipoprotein , diabetes mellitus , lipoprotein , cholesterol , basal insulin , stomach
Glucagon-like peptide-1 (GLP-1) agonists control postprandial glucose and lipid excursion in type 2 diabetes; however, the mechanisms are unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom